4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-056182
President & CEO sold 19,877 shares at $0.49 ($9,740)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2023-11-17 | Sale | −19,877 | $0.49 | $9,740 | 899,922 | D: show line 1 in the form |
| Open-market sales · 19,877 sh · avg $0.49 · $9,740 | |||||||
Loading xslF345X05/doc4.xml…